Erratum: The complex interplay among factors that influence allelic association (Nature Reviews Genetics (2004) 5 (89-100) DOI: 10.1038/nrg1270);The complex interplay among factors that influence allelic association

Nature Reviews Genetics

Volumn 5, Issue 2, 2004, Pages 89-100

  Zondervan, Krina T ^a   Cardon, Lon R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5 LEIDEN; CASPASE; GLUTATHIONE TRANSFERASE; MICROSATELLITE DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REPETITIVE DNA;

ALLELE; ALZHEIMER DISEASE; BLADDER CANCER; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; DEEP VEIN THROMBOSIS; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0742288585     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1314     Document Type: Erratum

References (56)

1. Botstein, D. & Risch, N. Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Nature Genet. 33 (Suppl), 228-237 (2003). Excellent overview of complex disease mapping, with anticipations for the focus of the next few years.
2. Risch, N. & Merikangas, K. The future of genetic studies of complex human diseases. Science 273, 1516-1517 (1996).
3. Weiss, K. M. & Terwilliger, J. D. How many diseases does it take to map a gene with SNPs? Nature Genet. 26, 151-157 (2000).
4. Risch, N. J. Searching for genetic determinants in the new millennium. Nature 405, 847-856 (2000).
5. Cardon, L. R. & Bell, J. I. Association study designs for complex diseases. Nature Rev. Genet 2, 91-99 (2001).
6. Clark, A. G. Finding genes underlying risk of complex disease by linkage disequilibrium mapping. Curr. Opin. Genet. Dev. 13. 296-302 (2003).
7. Chakravarti, A. It's raining SNPs, hallelujah? Nature Genet, 19, 216-217 (1998).
8. Johnson, G. C. et al. Haplotype tagging for the identification of common disease genes. Nature Genet, 29, 233-237 (2001).
9. Clayton, D. & McKeigue, P. M. Epidemiological methods for studying genes and environmental factors in complex disease. Lancet 358, 1356-1360 (2001). Clear description of the advantages, disadvantages and applications of different epidemiological design methods in the study of genetic and environmental factors in complex disease aetiology. Also a useful background for the increasingly popular country-wide 'Biobank' projects.
10. Rothman, K. J. & Greenland, S. in Modern Epidemiology (eds Rothman, K. J. & Greenland, S.) 79-92 (Lippincott-Raven, Philadelphia, 1998).
11. Rothman, K. J. & Greenland, S. in Modern Epidemiology (eds Rothman, K. J. & Greenland, S.) 93-114 (Lippincott-Raven, Philadelphia, 1998).
12. Schlesselman, J. J. Case-Control Studies. Design, Conduct, Analysis (Oxford Univ. Press, New York, 1982).
13. Pritchard, J. K. & Donnelly, P. Case-control studies of association in structured or admixed populations. Theor. Popul. Biol. 60, 227-237 (2001).
14. Greenland, S. & Rothman, K. J. in Modern Epidemiology (eds Rothman, K. J. & Greenland, S.) 47-64 (Lippincott-Raven, Philadelphia, 1998).
15. Kirkwood, B. R. Cohort and Case-Control Studies. Essentials of Medical Statistics 173-183 (Blackwell Scientific Publications, Oxford, 1988).
16. Altman, D. G. in Practical Statistics for Medical Research (ed. Altman, D. G.) 231-276 (Chapman and Hall, London, 1991).
17. Khoury, M. J., Beaty, T. H. & Cohen, B. H. Fundamentals of Genetic Epidemiology (Oxford Univ. Press, New York, 1993).
18. Altmuller, J., Palmer, L. J., Fischer, G., Scherb, H. & Wjst, J. Genomewide scans of complex human diseases: true linkage is hard to find. Am. J. Hum. Genet. 69, 936-950 (2001).
19. Roses, A. D. A model for suceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer's disease. Neurogenet. 1, 3-11 (1997).
20. Peto, R. et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321, 323-329 (2000).
21. Weiss, K. M. & Clark, A. G. Linkage disequilibdum and the mapping of complex human traits. Trends Genet. 18, 19-24 (2002).
22. Dawson, E. et al. A first-generation linkage disequilibrium map of human chromosome 22. Nature 418, 544-548 (2002).
23. Phillips, M. S. et al. Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nature Genet. 33, 382-387 (2003).
24. Cardon, L. R. & Abecasis, G. R. Using haplotype blocks to map human complex trait loci. Trends Genet. 19, 135-140 (2003).
25. Ardlie, K. G., Kruglyak, L. & Seielstad, M. Patterns of linkage disequilibrium in the human genome. Nature Rev. Genet. 3, 299-309 (2002). Detailed review of LD in the human genome and its possible origins and applications.
26. Couzin, J. Human genome. HapMap launches with pledges of $100 million. Science 298, 941-942 (2002).
27. Couzin, J. New mapping project splits the community. Science 296, 1391-1392 (2002).
28. Wall, J. D. & Pritchard, J. K. Haplotype blocks and linkage disequilibrium in the human genome. Nature Rev. Genet. 4, 587-597 (2003).
29. Hedrick, P. W. Gametic disequilibrium measures: proceed with caution. Genetics 117, 331-341 (1987).
30. Devlin, B. & Risch, N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29, 311-322 (1995).
31. Lewontin, R. C. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49, 49-67 (1964).
32. Pritchard, J. K. & Przeworski, M. Linkage disequilibrium in humans: models and data. Am. J. Hum. Genet. 69, 1-14 (2001).
33. Reich, D.E. et al. Linkage disequilibrium in the human genome. Nature 411, 199-204 (2001).
34. Abecasis, G. R. et al. Extent and distribution of linkage disequilibrium in three genomic regions. Am. J. Hum. Genet. 68, 191-197 (2001).
35. Kruglyak, L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nature Genet. 22, 139-144 (1999).
36. Pritchard, J. K. & Cox, N. J. The allelic architecture of human disease genes: common disease-common variant ... or not? Hum. Mol. Genet. 11, 2417-2423 (2003).
37. Reich, D. E. & Lander, E. S. On the allelic spectrum of human disease. Trends Genet. 17, 502-510 (2001).
38. Wright, A. F. & Hastie, N. D. Complex genetic diseases: controversy over the Croesus code. Genome Biol. 2, comment 2007.1-2007.8 (2001).
39. Terwilliger, J. D. & Weiss, K. M. Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr. Opin. Biotechnol. 9, 578-594 (1998). A strong case against the CDCV hypothesis and details the implications of this premise for LD mapping of complex traits.
40. Pritchard, J. K. Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 69, 124-137 (2001).
41. Smith, D. J. & Lusis, A. J. The allelic structure of common disease. Hum. Mol. Genet. 11, 2455-2461 (2002).
42. Wright, A. A polygenic basis for late onset disease. Trends Genet. 19, 97-106 (2003).
43. Chapman, J. M., Cooper, J. D., Todd, J. A. & Clayton, D. G. Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum. Hered. 56, 18-31 (2003).
44. Thompson, E. A., Deeb, S., Walker, D. & Motulsky, A. G. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet. 42, 113-124 (1998).
45. Muller-Myhsok, B. & Abel, L. Genetic analysis of complex diseases (comments on Risch & Merikangas). Science 275, 1328-1329 (1997). An early description of the importance of the similarity between disease and marker allele frequency in the power of association detection.
46. Abecasis, G. R., Cookson, W. O. & Cardon, L. R. The power to detect linkage disequilibrium with quantitative traits in selected samples. Am. J. Hum. Genet. 68, 1463-1474 (2001).
47. Bertina, R. M. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67 (1994).
48. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
49. Rubinsztein, D. C. & Easton, D. F. Apolipoprotein E genetic variation and Alzheimer's disease. A meta-analysis. Dement. Gariatr. Cogn Disord. 10, 199-209 (1999).
50. Engel, L. S. et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am. J. Epidemiol. 156, 95-109 (2002).
51. Altshuler, D. et al. The common PPARgamma Pro 12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genet. 26, 76-80 (2000).
52. Roses, A. D. Pharmacogenetics and the practice of medicine. Nature 405, 857-865 (2000).
53. Antoniou, A. C. & Easton, D. F. Polygenic inheritance of breast cancer: implications for design of association studies. Genet. Epidemiol. 25, 190-202 (2003). Recent paper that describes an example of the use of enrichment in epidemiological study design of traits with polygenic origin, and its influence on power in case-control studies.
54. Risch, N. & Teng, J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. I. DNA pooling. Genome Res. 8, 1273-1288 (1998). Provides the fundamental equations that describe the relationship between the marker OR detected in a case-control study and the disease OR, marker allele frequency and disease allele frequency.
55. Ackerman, H. et al. Haplotypic analysis of the TNF locus by association efficiency and entropy. Genome Biol. 4, R24 (2003).
56. Fleiss, J. L., Tytun, A. & Ury, H. K. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 36, 343-346 (1980).